Your browser doesn't support javascript.
loading
The FATIGUE-PRO: a new patient-reported outcome instrument to quantify fatigue in patients affected by systemic lupus erythematosus.
Morel, Thomas; Cano, Stefan; Bartlett, Susan J; Gordon, Caroline; Haier, Birgit; Regnault, Antoine; Schneider, Matthias; Stach, Christian; Cleanthous, Sophie.
Afiliação
  • Morel T; UCB Pharma, Brussels, Belgium.
  • Cano S; Modus Outcomes, Letchworth Garden City, UK.
  • Bartlett SJ; Department of Medicine, McGill University, Montreal, Quebec, Canada.
  • Gordon C; Rheumatology Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
  • Haier B; UCB Pharma, Monheim am Rhein.
  • Regnault A; Modus Outcomes, Letchworth Garden City, UK.
  • Schneider M; Poliklinik und Funktionsbereich für Rheumatologie, Heinrich-Heine-Universität, Düsseldorf, Germany.
  • Stach C; UCB Pharma, Monheim am Rhein.
  • Cleanthous S; Modus Outcomes, Letchworth Garden City, UK.
Rheumatology (Oxford) ; 61(8): 3329-3340, 2022 08 03.
Article em En | MEDLINE | ID: mdl-34897375
ABSTRACT

OBJECTIVES:

This study aimed to implement a patient-centred and evidence-based approach to develop a novel patient-reported outcome (PRO) instrument to measure fatigue in patients with SLE.

METHODS:

A three-step mixed methods psychometric (MMP) approach was followed. Steps comprised first draft item generation and review using interview data; evaluation and refinement of second draft items using mixed methods data, including interview and quantitative data from a phase 2 clinical study in SLE analysed using Rasch Measurement Theory (RMT) analysis; and evaluation of the final FATIGUE-PRO items using RMT and complementary Classical Test Theory (CTT) analyses. Guided by MMP criteria, a team of clinicians and outcome-measurement experts assessed evidence to inform instrument development.

RESULTS:

Step 1 culminated in 55 items (n = 39 patients interviewed). Their refinement in step 2 using mixed methods evidence led to the final FATIGUE-PRO instrument comprising 31 items across three scales of fatigue physical fatigue (9 items), mental and cognitive fatigue (11 items) and susceptibility to fatigue (11 items). Qualitative (n = 43 patients) and quantitative (n = 106 patients) evidence strongly supported the scales' content comprehensiveness and targeting, item quality and fit, conceptual uniqueness and appropriateness of the response scale. The FATIGUE-PRO further benefited from excellent reliability (RMT 0.92-0.94 and CTT 0.95-0.96) and supportive evidence of construct validity from assessments against other PROs.

CONCLUSION:

The conceptual advances, comprehensive coverage and strong psychometric properties of the FATIGUE-PRO will significantly advance the measurement and management of fatigue in SLE, both in clinical trials and routine practice. TRIAL REGISTRATION ClinicalTrials.gov (https//clinicaltrials.gov), NCT02804763.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medidas de Resultados Relatados pelo Paciente / Lúpus Eritematoso Sistêmico Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Medidas de Resultados Relatados pelo Paciente / Lúpus Eritematoso Sistêmico Tipo de estudo: Qualitative_research Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article